Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.03 from other evidence | 0.00 |
| cell type Human Protein Atlas | expressed broadly, no clear home in brain cells | 0.40 |
| chemistry Open Targets | a small-molecule pocket | 0.60 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 9 Parkinson's papers of 145 | 0.70 |
| pathways Reactome | 8 pathways; mostly vesicle traffic | 1.00 |
No case: the score is under the bar. Receipt 6580
Sealed predictions
- YKT6 in dopamine neurons, braak-0.18 (p 0.639) → -0.20 (p 0.613)receipt 6588
Swarm cases
receipt 6588: YKT6 in dopamine neurons, braak
- power
- full sample -0.14 (p 0.573, n 18), 95% CI -0.57 to +0.35. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.18 (p 0.476, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.23 (p 0.360, n 18). could be the mix.
- skeptic
- leave-one-out range -0.28 to -0.04, sign flips 0; without severely affected donors -0.14 (p 0.573, n 18). fragile.
- cell type
- strongest in OPCs: -0.60 (p 0.0089, n 18) vs -0.14 in dopamine neurons. proposing OPCs.
- axis
- no measure beats "tracks Braak Lewy-body stage" for YKT6 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up YKT6 · OPCs · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) -0.32 p 0.248 (needs p < 3.1e-4)
Receipts
loading the receipts